Karl Egerer

3.4k total citations
52 papers, 2.5k citations indexed

About

Karl Egerer is a scholar working on Immunology, Rheumatology and Molecular Biology. According to data from OpenAlex, Karl Egerer has authored 52 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 20 papers in Rheumatology and 16 papers in Molecular Biology. Recurrent topics in Karl Egerer's work include Systemic Lupus Erythematosus Research (13 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Ubiquitin and proteasome pathways (11 papers). Karl Egerer is often cited by papers focused on Systemic Lupus Erythematosus Research (13 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Ubiquitin and proteasome pathways (11 papers). Karl Egerer collaborates with scholars based in Germany, United States and United Kingdom. Karl Egerer's co-authors include Eugen Feist, Thomas Dörner, Gerd R Burmester, Wolfgang J. Kox, Andrew J.S. Coats, Hans‐Dieter Volk, G.-R. Burmester, Stefan D. Anker, Paul Rudolph and Gerd‐Rüdiger Burmester and has published in prestigious journals such as Blood, Neurology and FEBS Letters.

In The Last Decade

Karl Egerer

51 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl Egerer Germany 26 900 703 650 440 418 52 2.5k
Shin‐ya Kawashiri Japan 27 1.3k 1.5× 642 0.9× 745 1.1× 349 0.8× 135 0.3× 223 3.0k
Gyula Szegedi Hungary 30 1.4k 1.5× 362 0.5× 873 1.3× 492 1.1× 249 0.6× 96 2.6k
Ann‐Kristin Ulfgren Sweden 21 1.5k 1.7× 609 0.9× 1.4k 2.1× 764 1.7× 374 0.9× 30 3.3k
Birgitta Sundelin Sweden 29 738 0.8× 605 0.9× 559 0.9× 193 0.4× 255 0.6× 54 2.5k
Yoshitaka Morita Japan 26 775 0.9× 659 0.9× 1.0k 1.6× 251 0.6× 168 0.4× 105 2.7k
Barbara Tolusso Italy 30 1.3k 1.4× 584 0.8× 961 1.5× 311 0.7× 246 0.6× 129 2.9k
Shintaro Hirata Japan 29 1.1k 1.2× 407 0.6× 457 0.7× 206 0.5× 214 0.5× 161 2.5k
Satoshi Yamasaki Japan 32 775 0.9× 606 0.9× 793 1.2× 326 0.7× 122 0.3× 188 3.1k
Emese Kiss Hungary 34 2.0k 2.2× 352 0.5× 1.2k 1.9× 379 0.9× 366 0.9× 130 3.2k
Pieter C. Limburg Netherlands 38 1.2k 1.4× 670 1.0× 1.7k 2.6× 459 1.0× 267 0.6× 79 3.8k

Countries citing papers authored by Karl Egerer

Since Specialization
Citations

This map shows the geographic impact of Karl Egerer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Egerer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Egerer more than expected).

Fields of papers citing papers by Karl Egerer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Egerer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Egerer. The network helps show where Karl Egerer may publish in the future.

Co-authorship network of co-authors of Karl Egerer

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Egerer. A scholar is included among the top collaborators of Karl Egerer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Egerer. Karl Egerer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flörcken, Anne, Joachim Kopp, Antje van Lessen, et al.. (2013). Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer. Human Vaccines & Immunotherapeutics. 9(6). 1217–1227. 27 indexed citations
2.
Ljung, Lotta, Karl Egerer, Holger Bang, et al.. (2011). New Assay Generation for Antibodies Against Modified and Citrullinated Peptides Predicts Poor Response to TNF Inhibitor Therapy. Arthritis & Rheumatism. 63(10). 1 indexed citations
3.
Kaup, Matthias, Karl Egerer, Andreas Weimann, et al.. (2011). Profiling of Endo H‐released serum N‐glycans using CE‐LIF and MALDI‐TOF‐MS – Application to rheumatoid arthritis. Electrophoresis. 32(24). 3510–3515. 18 indexed citations
4.
Egerer, Karl, Dirk Roggenbuck, Thomas Büttner, et al.. (2011). Single-step autoantibody profiling in antiphospholipid syndrome using a multi-line dot assay. Arthritis Research & Therapy. 13(4). R118–R118. 31 indexed citations
5.
Voigt, Antje, Christiane Trimpert, Karl Egerer, et al.. (2010). Lack of evidence for a pathogenic role of proteasome-directed autoimmunity in dilated cardiomyopathy. Basic Research in Cardiology. 105(4). 557–567. 5 indexed citations
6.
Bang, Holger, Eugen Feist, G Fredenhagen, et al.. (2010). Immediate determination of ACPA and rheumatoid factor - a novel point of care test for detection of anti-MCV antibodies and rheumatoid factor using a lateral-flow immunoassay. Arthritis Research & Therapy. 12(3). R120–R120. 21 indexed citations
7.
Hanke, Katharina, Claudia Brückner, Cornelia Dähnrich, et al.. (2009). Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients. Arthritis Research & Therapy. 11(1). R22–R22. 85 indexed citations
8.
Egerer, Karl, Eugen Feist, & Gerd‐Rüdiger Burmester. (2009). The Serological Diagnosis of Rheumatoid Arthritis. Deutsches Ärzteblatt international. 106(10). 159–63. 42 indexed citations
9.
Morawietz, Lars, Lorena Martinez‐Gamboa, Gert Hausdorf, et al.. (2009). Expression of Proteasomal Immunosubunit ß1i Is Dysregulated in Inflammatory Infiltrates of Minor Salivary Glands in Sjögren’s Syndrome. The Journal of Rheumatology. 36(12). 2694–2703. 12 indexed citations
10.
Voigt, Antje, Karl Egerer, Christiane Trimpert, et al.. (2009). Humoral anti-proteasomal autoimmunity in dilated cardiomyopathy. Basic Research in Cardiology. 105(1). 9–18. 12 indexed citations
11.
Kuckelkorn, Ulrike, Karl Egerer, Thomas Dörner, et al.. (2008). Autoimmune reactivity against the 20S-proteasome includes immunosubunits LMP2 ( 1i), MECL1 ( 2i) and LMP7 ( 5i). Lara D. Veeken. 47(5). 622–626. 15 indexed citations
12.
Martinez‐Gamboa, Lorena, Anja Dankof, Bruno Stuhlmüller, et al.. (2006). Tissue‐specific up‐regulation of the proteasome subunit β5i (LMP7) in Sjögren's syndrome. Arthritis & Rheumatism. 54(5). 1501–1508. 56 indexed citations
13.
Dörner, Thomas, Karl Egerer, Eugen Feist, & Gerd R Burmester. (2004). Rheumatoid factor revisited. Current Opinion in Rheumatology. 16(3). 246–253. 174 indexed citations
14.
Egerer, Karl, et al.. (2003). sE‐selectin for stratifying outcome in rheumatoid arthritis. Arthritis Care & Research. 49(4). 546–548. 17 indexed citations
15.
Doehner, Wolfram, Mathias Rauchhaus, Ian F. Godsland, et al.. (2002). Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha. International Journal of Cardiology. 83(1). 73–81. 59 indexed citations
16.
Doehner, Wolfram, Mathias Rauchhaus, IF Godsland, et al.. (2001). Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia. European Journal of Endocrinology. 145(6). 727–735. 88 indexed citations
17.
Lehmann, Christine, et al.. (1999). Inhibition of tumor necrosis factor-alpha release in rat experimental endotoxemia by treatment with the 21-aminosteroid U-74389G. Critical Care Medicine. 27(6). 1164–1167. 16 indexed citations
18.
Hensel, Mario, Thomas Volk, W D Döcke, et al.. (1998). Hyperprocalcitonemia in Patients with Noninfectious SIRS and Pulmonary Dysfunction Associated with Cardiopulmonary Bypass . Anesthesiology. 89(1). 93–104. 105 indexed citations
19.
Egerer, Karl, et al.. (1997). Die zirkulierenden Adhäsionsmoleküle sICAM-1 und sE-Selectin bei Patienten mit Sepsis. Der Anaesthesist. 46(7). 592–598. 5 indexed citations
20.
Anker, Stefan D., et al.. (1997). Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. The American Journal of Cardiology. 79(10). 1426–1430. 310 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shin‐ya Kawashiri Breakdown of academic impact, for papers by Gyula Szegedi Breakdown of academic impact, for papers by Ann‐Kristin Ulfgren Breakdown of academic impact, for papers by Birgitta Sundelin Breakdown of academic impact, for papers by Yoshitaka Morita Breakdown of academic impact, for papers by Barbara Tolusso Breakdown of academic impact, for papers by Shintaro Hirata Breakdown of academic impact, for papers by Satoshi Yamasaki Breakdown of academic impact, for papers by Emese Kiss Breakdown of academic impact, for papers by Pieter C. Limburg
Rankless by CCL
2026